Omnilux, Dr. Squatch, and Plexaderm were the most effective at driving consumer behavior, according to EDO’s investment-grade data
EDO, the TV outcomes company, has released its Body & Skincare Convergent TV Outcomes Report, detailing the industry's linear and streaming TV ad performance in Q4 2024. The report highlights how Body & Skincare brands leveraged convergent TV to drive consumer behaviors that are most predictive of future sales – like brand searches and site visits – with streaming serving as a valuable platform for advertisers looking to enhance engagement.
Per EDO, Body & Skincare ads were 3% more effective at generating consumer engagement on streaming than on linear TV. As more advertisers shift their focus to convergent TV, understanding which platforms, demographics, and creative strategies drive the most engagement has never been more critical. EDO's investment-grade data provides advertisers with a clear view of how their campaigns drive business outcomes.
“Our analysis underscores the power of effective advertising for brands like Omnilux, CeraVe, and Dr. Squatch, revealing that targeted, strategic investments in streaming drive strong engagement,” said Laura Grover, SVP, Head of Client Solutions at EDO. “By pinpointing what resonates — from top-performing creatives to high-engagement markets — advertisers can optimize their convergent campaigns for even greater success.”
"EDO's analysis reveals that targeted, strategic TV investments from brands like Dove, CeraVe, and Dr. Squatch drove highly effective convergent campaigns in Q4," said Laura Grover, SVP, Head of Client Solutions at EDO. “Advertisers can achieve greater success by optimizing their campaigns using immediate, cross-platform performance data to identify high-performing demographics, markets, and more.”
Key findings from EDO’s Body & Skincare Convergent TV Outcomes Report include:
Download EDO’s Body & Skincare Convergent TV Outcomes Report to know what’s working for advertisers.